Treating EGFR Mutant NSCLC in Brazil
Evolving Role of Liquid Biopsy for Lung Cancer
ASCO 2023 Highlights
WCLC 2023 Preview
LCC in Polish: Overcoming Barriers to Lung Cancer Therapy in Poland
Decoding ROS1 Fusions in Lung Cancer
LCC in Italian: Updates in Resectable NSCLC
SCLC Transformation in EGFR NSCLC
ADAURA and the Evolving Role of Targeted Therapy
Meeting the New JTO CRR Editor in Chief
LCC in French: Managing Locally Advanced NSCLC
ELCC 2023 Highlights
EGFR Mutant NSCLC Post Osimertinib
SCLC 2023 Meeting Preview
Targeted Therapies - Consolidated Radiation
TTLC 2023 Meeting Recap
Virtual Tumor Board: Resectable Stage III NSCLC
EGFR Exon 20 Insertions in NSCLC
RET Fusions in NSCLC: Current Management
Targeting KRAS G12C in NSCLC
LALCA 2023 Highlights
FDA Approval of Adjuvant Pembrolizumab for NSCLC
Seminal Trials: IPASS for EGFR NSCLC
LCC in Portuguese: Treating Lung Cancer in Brazil
Patient Advocacy Groups for NSCLC
Radon: An Important Risk Factor for Lung Cancer
FDA Approval: Adagrasib for KRAS G12C NSCLC
LCC in Hebrew: Treating Lung Cancer in Israel
ACLC & ESMO Asia 2022 Highlights
LCC in Arabic: Lung Cancer in the MENA Region
MET as a NSCLC Target
FDA Approval: 1L Cemiplimab + Chemotherapy for NSCLC
FDA Approval: 1L Durvalumab + Tremelimumab + Chemotherapy for NSCLC
Climate Change & Lung Cancer - Part Two
Evolution of Treating Stage III NSCLC
Seminal Trials Series: ECOG 1594
Lung Cancer Care in the Rural US
LCC in Mandarin Chinese: Treating Lung Cancer in China
LCC in Japanese: Treating Lung Cancer in Japan
Current Role of Liquid Biopsy in NSCLC
ESMO 2022 Highlights
Role of the Interventional Pulmonologist in Managing Lung Cancer
Role of the Pathologist in Managing Lung Cancer
NACLC 2022 Wrap Up
Finding Your First Job in Oncology
Mesothelioma Updates
Virtual Tumor Board: Advanced PD-L1 Negative NSCLC
New FDA Approval: Trastuzumab Deruxtecan (TDXd)
WCLC 2022 Wrap Up
WCLC 2022 Daily Highlights - August 9
Destacados Diarios WCLC 2022 - 8 de Agosto (Presented in Spanish)
WCLC 2022 Daily Highlights - August 8
WCLC 2022 Daily Highlights - August 7
WCLC 2022 Preview with Meeting Chairs
Impact of IASLC Fellowship and Grant Funding
WCLC 2022 Preview
Women in Thoracic Oncology
LCC in German: Treating Lung Cancer in Germany
Treating Lung Cancer in South Africa
The Journey of International Medical Graduates in Thoracic Oncology
ASCO 2022 Highlights
Antibody Drug Conjugates (ADCs) in NSCLC
Treating Lung Cancer in India
Smoking Cessation and Stigma of Lung Cancer
Lung Cancer Screening Overview
Climate Change and Lung Cancer: Part One
Meeting Dr. Karen Kelly, IASLC CEO | 100th Episode
ELCC 2022 Highlights
Targeting NTRK in NSCLC
TTLC 2022 Highlights
Overview of NTRK as a Target
Targeting ALK in NSCLC
Overview of EGFR in NSCLC
Cell Therapy: A New Frontier for Thoracic Cancers
Virtual Tumor Board: EGFR Mutant NSCLC
ESMO 2022 NSCLC Highlights
ASCO 2022 - Meeting Highlights
Emerging Perioperative Treatment Using Immune Checkpoint Inhibitors in Patients with Resectable NSCLC
Updates on Liquid Biopsy for Advanced NSCLC: A Consensus Statement from the IASLC
Women In Thoracic Oncology
Tips and Tricks for Navigating IASLC WCLC
WCLC 2020 Highlights
Targeting RET in NSCLC
Understanding EGFR Resistance
Emerging Treatments for ROS1 NSCLC
Developing the Moderna Covid-19 Vaccine
Virtual Tumor Board: Advanced Squamous NSCLC
ELCC 2021 Highlights
Understanding ALK Fusions in NSCLC
Virtual Tumor Board: Mesothelioma
Understanding KRAS G12C in NSCLC
Seminal Trials - KEYNOTE 001
Virtual Tumor Board: Locally Advanced NSCLC
Understanding FDA Approvals
Neoadjuvant Immunotherapy for NSCLC: A New Frontier
ASCO 2021 Highlights
Financial Toxicity in Cancer Care
LCC in Italian: Treating Lung Cancer in Italy
Meet IASLC Member Dr. Tom John
Virtual Tumor Board: Metastatic KRAS non-G12C NSCLC
Targeting HER2 in NSCLC
Targeting BRAF in NSCLC
Meet the IASLC President - Elect Dr. Paul Van Schil
WCLC 2021 Highlights
Peer to Peer: Issues, Strategies, and Impact
Politics and Oncology
ESMO 2021 Highlights
Virtual Tumor Board: Advanced Small Cell Lung Cancer
Small Cell Lung Cancer: Current Standards and Future Directions
The White Ribbon Project
Interview With Jason Day: PGA Golfer and Lung Cancer Advocate
Virtual Tumor Board: Surgery and Radiation for Stage III NSCLC
LCC in Korean: Treating Lung Cancer in Korea
The IASLC and Global Advocacy
IASLC STARS Program
Virtual Tumor Board: Multidisciplinary Approach to Stage III NSCLC
LCC in Spanish: LALCA 2021 Highlights
NRG1 as a Therapeutic Target
2021 World Conference on Lung Cancer (WCLC) Highlights
Global Access to Radiotherapy for Lung Cancer
Prehabilitation: Optimizing Patients to Improve Outcomes - Part 2
Prehabilitation: Optimizing Patients to Improve Outcomes - Part 1
Challenging Cases in Lung SBRT
2020 World Conference on Lung Cancer (WCLC) Highlights
State-of-the-Art in Combination Immuno/Radiotherapy for Non-Small Cell Lung Cancer
Managing Clinical and Translational Research During COVID
E-Cigarette and Vaping Policy with Dr. Matthew Steliga
American Cancer Society Report with CSO Dr. Chandra Belani
Interview with IASLC Chief Science Officer Dr. Chandra Belani
IASLC 2020 Lung Cancer Targeted Therapies Meeting
Highlights from 20th IASLC 2020 Lung Cancer Targeted Therapies Conference
Interview with IASLC President - Dr. Tetsuya Mitsudomi
COVID-19 Facts and Impacts for the Lung Cancer Community
COVID-19 JTO Report with Dr. Shu-Yuan Xiao
JTO Study on Smoking Cessation Impact with Dr. Rafael Meza
COVID-19 Guidelines for Patients with Lung Cancer with Dr. Erin Bange
How To Find Information on COVID-19 In Different Regions - Spanish Language
Around The World: COVID-19 and Lung Cancer Tips and Experiences
What Patients Need to Know About Lung Cancer Research in the Era of COVID-19
IASLC Radiation Oncology and COVID-19 Webinar Recap
American Society of Clinical Oncology Virtual Meeting Highlights
Post AACR Debrief with Dr. Greg Riely
COVID-19 Impact on Conferences and Social Media with Dr. Tatiana Prowell from the FDA
Tumor Mutational Burden and COVID-19: A Pathologist’s Perspective
ADAURA: A Lively Debate Among Key Voices
Pros and Cons of Telemedicine
The IASLC Pathology Committee’s Creation of the IHC Atlas
IASLC Hot Topics on Liquid Biopsy
Digital Connections as an Educational Tool
Equity in Medicine
Throwback to WCLC 2019
Immunotherapy for Lung Cancer Patients with Dr. Matt Hellman
Changing the Conversation: Overcoming Stigma Through Language and Action
Continuing the Conversation: Overcoming Lung Cancer Stigma
Practicing Medicine and Obtaining Treatments in Low & Middle-Income Countries
Supportive Care of Lung Cancer Patients during COVID-19
Artificial Intelligence and Cost Effectiveness in Lung CT Screening
STARS Webinar - Cancer Drug Development in the Era of Precision Medicine
Practical Practice Recommendations for Lung Cancer Radiotherapy During the COVID-19 Pandemic: An ESTRO-ASTRO Consensus Statement
The Evolution of Small Cell Lung Cancer
A Conversation With IASLC President, Giorgio Scagliotti
A Conversation With Medical Oncologist Joan Schiller
Blood Based Testing And The Evolution Of Lung Cancer With Dr. David Gandara
Medication For Lung Cancer Treatment With Dr. David Spigel
Radiation Oncology And Proton Therapy, Dr. Walter J. Curran
A Conversation With Thoracic Oncologist Dr. Corey Langer
State Of Mesothelioma Treatment With Dr. Anne Tsao
NGS Testing & Participation And Funding In Clinical Trials with Dr. Alexander Drilon
The Journal Of Thoracic Oncology With Dr. Adjei
Highlights From 2019 ASCO Annual Meeting With Dr. Christine Lovly
Lung Cancer Trends in Europe with Clinical Chief Dr. Rami Porta
Lung Cancer Trends in Australia with Dr. Ben Solomon at IASLC 2019 WCLC
IASLC 2019 WCLC Highlights with Dr. Tony Mok
Women Leaders in Lung Cancer with Dr. Heather Wakelee and Professor Corinne Faivre-Finn
Women In Lung Cancer- Patient Advocacy
Lung Cancer Research Trends in France with Dr. Benjamin Besse at IASLC 2019 WCLC
CT Lung Cancer Screening with First Responders with Dr. Vershalee Shukla
The Formation of the Lung Ambition Alliance
IASLC Tobacco Declaration: IASLC Statement on Tobacco Control and Smoking Cessation (English, Chinese, Japanese, Polish, Portuguese, Spanish)
Healthcare Providers, Tobacco Control and Smoking Cessation Brochure
Special Article: Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
The IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer
Patient Resource: What You Need to Know About Reading a Biomarker Test Report
The IASLC Atlas of Diagnostic Immunohistochemistry (IHC)
Caregiver Survey: Taking Care of Caregivers - English
Caregiver Survey: Atendiendo a los Cuidadores - Spanish
Caregiver Survey: 关心护理人员 - Chinese
Caregiver Survey: Prendre soin des Aidants - French
Caregiver Survey: Die Betreuung von Pflegenden - German
The IASLC Atlas of PD-L1 Testing in Lung Cancer
IASLC Atlas of EGFR Testing in Lung Cancer
Staging Handbook in Thoracic Oncology, 2nd Edition
Staging Project Resource Poster: 8th Edition TNM Classification of Lung Nonmucinous AIS, MIA, and Lepidic Predominant Adenocarcinoma
Staging Project Poster: 8th Edition Lung Cancer TNM Staging Summary Poster
Staging Laminate Reference Cards, 8th Edition
Quick Reference Guide to COVID-19 and Cancer
COVID-19 in Thoracic Oncology Patients
WCLC 2023 Recap Podcast
2023 Latin America Conference on Lung Cancer
2023 Small Cell Lung Cancer (SCLC) Meeting
2022 Targeted Therapies of Lung Cancer Meeting (TTLC) - Slides
2022 North America Conference on Lung Cancer (Slides)
2022 Asia Conference on Lung Cancer (ACLC)
2022 World Conference on Lung Cancer
2023 Targeted Therapies of Lung Cancer Meeting
IASLC Language Guide
STARS Webinar - What Do All Those Lines and Colors Mean? Interpreting Cancer Data Plots
The Impact of Lung Cancer on Intimate Relationships
2023 WCLC Highlights Webinar
2023 ASCO Highlights Webinar
Current Approaches and Future Directions in Radiotherapy for Small Cell Lung Cancer (SCLC)
Emerging ADCs and Their Role in Advanced Lung Cancer Treatment
KOL Knockout TM: Cancer Pain Management Edition
The Amazing Case Race Microlearning: Case Study 1 - Navigating into the Deep of Molecular Profiling of NSCLC
2023 World Conference on Lung Cancer - Live/Hybrid Attendee Access
2021 Targeted Therapies of Lung Cancer (TTLC) Meeting
2021 World Conference on Lung Cancer (WCLC)
IASLC 诊断免疫 组织化学图谱 - Chinese (Atlas of Diagnostic Immunohistochemistry)
IASLC 免疫組織化学診断 IASLCアトラス - Japanese (Atlas of Diagnostic Immunohistochemistry)
Atlas De Inmunohistoquímica Diagnóstica De La IASLC - Spanish
The IASLC Atlas of ALK and ROS1 Testing in Lung Cancer
STARS Webinar - From WCLC23 to You: Presented by Lung Cancer Research Advocates (with audio translations)
2023 Radiation Oncology Update
The Amazing Case Race Microlearning: Case Study 2 - Diagnosis and Management of Pleural Mesothelioma in the Era of Immunotherapy
The Amazing Case Race Microlearning: Case Study 3 - Management of Care for Patients Diagnosed with Poorly Differentiated Carcinoma of the Lung
iMig 2023 Highlights
FDA Approval: Perioperative Pembrolizumab and KEYNOTE 671
FDA Approval: Repotrectinib, a ROS1 and NTRK Inhibitor
The Unspoken Subject: Sexual Health and Lung Cancer
Virtual Tumor Board: Neoadjuvant for Stage III NSCLC
LCC in Dutch: Lung Cancer Care in The Netherlands
AEGEAN and Beyond: Perioperative Immunotherapy for NSCLC
LCC in Hindi: Lung Cancer Care in India — Approaching a Lung Cancer Diagnosis
FDA Approval: Encorafenib + Binimetinib in BRAF V600E NSCLC
ESMO 2023 Highlights: Early-Stage NSCLC, SCLC, Thymic Carcinoma
ESMO 2023 Highlights: Metastatic NSCLC
LCC in Japanese: State of the Art for EGFR
LCC in Hungarian: Lung Cancer Care and Clinical Research in Hungary
Current and Future Treatment of Mesothelioma
North American Conference on Lung Cancer (NACLC) 2023 Preview
Live from WCLC 2023: Tuesday Highlights
MARS 2 in Spanish — Monday WCLC Highlights
Live from WCLC 2023: Monday Highlights
Live from WCLC 2023: Sunday Highlights
Gender Equity and Beyond, a Discussion with HRH Princess Dina Mired of Jordan
Drug Development and Targeted Therapies
LCC in Mandarin Chinese: EGFR in China - From Testing to Treating
Artificial Intelligence (AI) and Pathology
LCC in Greek: Treating Lung Cancer in Greece
IASLC Hot Topic in Basic and Translational Science Meeting Preview
Virtual Tumor Board: Relapsed SCLC
Atlas de Pruebas Moleculares para Terapias Dirigidas en Cáncer de pulmón de la IASLC - Spanish (The IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer)
肺癌における標的療法のための分子検査 の IASLC アトラス - Japanese (The IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer)
IASLC 肺癌靶向治疗 分子检测 图谱 - Chinese (The IASLC Atlas of Molecular Testing For Targeting Therapy in Lung Cancer)
2023 Hot Topic in Basic & Translational Science: Resistance to IO in NSCLC (HTIO23)
2023 North America Conference on Lung Cancer (NACLC) - Live/Hybrid Attendee Access
Research from NACLC: Nutrition as Medicine and Lung Cancer Screening
New Options for Initial Treatment of EGFR Mutant NSCLC
Alfonso Certificate Setup - Do not delete
2023 IASLC Academy Amazing Case Race - Thoracic Cancer Simulation
IASLC CT Screening Workshop
2023 ESMO Highlights Webinar
2023 North America Conference on Lung Cancer (NACLC) Highlights Webinar
LCC in Korean: Managing EGFR+ NSCLC
Review of Diagnostic and Therapeutic Implications of EGFR Exon 20 Insertions in Metastatic Non-Small Cell Lung Cancer
Journal of Thoracic Oncology (JTO), Sept 2023, Volume 18, Issue 9
Journal of Thoracic Oncology (JTO), Dec 2023, Volume 18, Issue 12
Journal of Thoracic Oncology (JTO), Nov 2023, Volume 18, Issue 11
Journal of Thoracic Oncology (JTO), Oct 2023, Volume 18, Issue 10
JTO Clinical and Research Reports, Nov 2023, Volume 4, Issue 11
IASLC Position Statement on the Documentation of Tobacco Use in Cancer Clinical Trials
IASLC Position Statement on Tobacco Cessation after a Cancer Diagnosis
IASLC Policy Statement - Electronic Cigarettes
IASLC Statement on Lung Cancer Screening with Low-Dose Computed Tomography
JTO Clinical and Research Reports, Oct 2023, Volume 4, Issue 10
JTO Clinical and Research Reports, Sept 2023, Volume 4, Issue 9
JTO Clinical and Research Reports, Aug 2023, Volume 4, Issue 8
JTO Clinical and Research Reports, July 2023, Volume 4, Issue 7
JTO Clinical and Research Reports, June 2023, Volume 4, Issue 6
JTO Clinical and Research Reports, May 2023, Volume 4, Issue 5
JTO Clinical and Research Reports, April 2023, Volume 4, Issue 4
JTO Clinical and Research Reports, March 2023, Volume 4, Issue 3
JTO Clinical and Research Reports, Feb 2023, Volume 4, Issue 2
JTO Clinical and Research Reports, Jan 2023, Volume 4, Issue 1
Chronic Toxicity with Targeted Therapy
Maximizing Supportive Care in Lung Cancer
JTO Clinical and Research Reports, Dec 2023, Volume 4, Issue 12
Journal of Thoracic Oncology (JTO), Aug 2023, Volume 18, Issue 8
Journal of Thoracic Oncology (JTO), July 2023, Volume 18, Issue 7
Journal of Thoracic Oncology (JTO), June 2023, Volume 18, Issue 6
Journal of Thoracic Oncology (JTO), May 2023, Volume 18, Issue 5
Journal of Thoracic Oncology (JTO), April 2023, Volume 18, Issue 4
Journal of Thoracic Oncology (JTO), March 2023, Volume 18, Issue 3
Journal of Thoracic Oncology (JTO), Feb 2023, Volume 18, Issue 2
Journal of Thoracic Oncology (JTO), Jan 2023, Volume 18, Issue 1
IASLC Lung Cancer News (ILCN), December 2023
STARS Webinar - Finding the Right Dose: Using Patient-Reported Data in Early Phase Clinical Trials
IASLC Lung Cancer News (ILCN), November 2023
IASLC Lung Cancer News (ILCN), October 2023
IASLC Lung Cancer News (ILCN), September 2023
IASLC Lung Cancer News (ILCN), August 2023
IASLC Lung Cancer News (ILCN), July 2023
IASLC Lung Cancer News (ILCN), June 2023
IASLC Lung Cancer News (ILCN), May 2023
IASLC Lung Cancer News (ILCN), April 2023
IASLC Lung Cancer News (ILCN), March 2023
IASLC Lung Cancer News (ILCN), February 2023
IASLC Lung Cancer News (ILCN), January 2023
IASLC Lung Cancer News (ILCN), December 2022
IASLC Lung Cancer News (ILCN), November 2022
IASLC Lung Cancer News (ILCN), October 2022
IASLC Lung Cancer News (ILCN), September 2022
IASLC Lung Cancer News (ILCN), August 2022
IASLC Lung Cancer News (ILCN), July 2022
IASLC Lung Cancer News (ILCN), June 2022
IASLC Lung Cancer News (ILCN), May 2022
IASLC Lung Cancer News (ILCN), April 2022
IASLC Lung Cancer News (ILCN), March 2022
IASLC Lung Cancer News (ILCN), February 2022
IASLC Lung Cancer News (ILCN), January 2022
The Basics of Pain Management for Cancer Patients from Diagnosis to Palliative Care – Thoracic Cancer Edition Course
2023 North America Conference on Lung Cancer (NACLC) - Extended Conference
The Basics of Pain Management for Cancer Patients: From Diagnosis to Palliative Care (Bundle)
2023 World Conference on Lung Cancer (WCLC) - Extended Conference
Air Pollution and Lung Cancer - The IASLC Position Statement
IASLC Letter to New Zealand - New Zealand Tobacco Action Plan
Journal of Thoracic Oncology (JTO), January 2024, Volume 19, Issue 1
Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
Oligometastatic NSCLC: Part 1
Management of Oligometastatic NSCLC: Part 2
IASLC Lung Cancer News (ILCN), January 2024
LCC in Arabic: Smoking and Smoking-Related Lung Cancer in MENA
Meet IASLC's Chief Science Officer: Dr. Jennifer King
The Basics of Pain Management for Cancer Patients from Diagnosis to Palliative Care: A Comprehensive Overview
LCC in Cantonese Chinese: Biomarker Testing and EGFR Mutant NSCLC
The IASLC's 50th Anniversary and New Strategic Plan
JTO Clinical and Research Reports, January 2024, Volume 5, Issue 1
Journal of Thoracic Oncology (JTO), February 2024, Volume 19, Issue 2
Cancer Pain Management: Patient Toolkit
IASLC Lung Cancer News (ILCN) Article Collection: Patient Perspectives
IASLC Lung Cancer News (ILCN) Article Collection: Artificial Intelligence
Bronchoscopic Ablation Therapy for Lung Malignancies Webinar
IASLC Lung Cancer News (ILCN), February 2024
LCC in Spanish: Barriers to Biomarker Testing
LCC in French Canadian: Barriers to Biomarker Testing
LCC in Mandarin Chinese: Barriers to Biomarker Testing
LCC in Portuguese: Barriers to Biomarker Testing
LCC in French: Barriers to Biomarker Testing
LCC in Cantonese Chinese: Barriers to Biomarker Testing
Biomarkers in Lung Cancer: Barriers to Implementation
LCC in Japanese: Barriers to Biomarker Testing
Best Practice for RET NSCLC
How to Publish with the Journal of Thoracic Oncology (JTO)
2024 Targeted Therapies of Lung Cancer Meeting (TTLC) - Live/Hybrid Attendee Access
From the Basics to Next Line Therapy: ALK + NSCLC
Seminal Trial Series: Nivolumab and Non-Small Cell Lung Cancer with Dr. Julie Brahmer
JTO Clinical and Research Reports, February 2024, Volume 5, Issue 2
FDA Approval: 1L Amivantamab Plus Chemotherapy for EGFR Exon 20 NSCLC
Journal of Thoracic Oncology (JTO), March 2024, Volume 19, Issue 3
Journal of Thoracic Oncology (JTO), December 2022, Volume 17, Issue 12
Journal of Thoracic Oncology (JTO), November 2022, Volume 17, Issue 11
Journal of Thoracic Oncology (JTO), October 2022, Volume 17, Issue 10
Journal of Thoracic Oncology (JTO), September 2022, Volume 17, Issue 9
Journal of Thoracic Oncology (JTO), August 2022, Volume 17, Issue 8
Journal of Thoracic Oncology (JTO), July 2022, Volume 17, Issue 7
Radiopharmaceuticals and Lung Cancer
Best of TTLC 2024 Webinar
IASLC Lung Cancer News (ILCN), March 2024
Emerging Agents in Small Cell Lung Cancer
2020 Targeted Therapies of Lung Cancer (TTLC) Meeting
JTO Clinical and Research Reports, March 2024, Volume 5, Issue 3
ELCC 2024 Highlights
FDA Approval: FLAURA2, First Line Osimertinib Plus Chemotherapy for EGFR NSCLC
The Amazing Case Race Microlearning: Case Study 4 - Definitive Treatment of Bilateral Lung Cancers with a Radiotherapy-Based Approach
Journal of Thoracic Oncology (JTO), April 2024, Volume 19, Issue 4
IASLC Lung Cancer News (ILCN), April 2024
IASLC DEI Initiative Global Member Survey
FDA Approval: Adjuvant Alectinib for Resected NSCLC
Journal of Thoracic Oncology (JTO), June 2022, Volume 17, Issue 6 (JTO062022)
Journal of Thoracic Oncology (JTO), May 2022, Volume 17, Issue 5 (JTO052022)
Journal of Thoracic Oncology (JTO), April 2022, Volume 17, Issue 4 (JTO042022)
Journal of Thoracic Oncology (JTO), March 2022, Volume 17, Issue 3 (JTO032022)
Journal of Thoracic Oncology (JTO), February 2022, Volume 17, Issue 2 (JTO022022)
Journal of Thoracic Oncology (JTO), January 2022, Volume 17, Issue 1 (JTO012022)
KRAS in NSCLC: Beyond G12C
JTO Clinical and Research Reports, April 2024, Volume 5, Issue 4
When Two Worlds Collide: Adenosquamous Histology
Journal of Thoracic Oncology (JTO), May 2024, Volume 19, Issue 5
JTO Clinical and Research Reports, December 2022, Volume 3, Issue 12
JTO Clinical and Research Reports, November 2022, Volume 3, Issue 11
JTO Clinical and Research Reports, October 2022, Volume 3, Issue 10 (CRR102022)
IASLC Lung Cancer News (ILCN), May 2024
Virtual Tumor Board: Metastatic PD-L1 Low NSCLC
JTO Clinical and Research Reports, January 2022, Volume 3, Issue 1 (CRR012022)
JTO Clinical and Research Reports, February 2022, Volume 3, Issue 2
JTO Clinical and Research Reports, March 2022, Volume 3, Issue 3
JTO Clinical and Research Reports, April 2022, Volume 3, Issue 4 (CRR042022)
JTO Clinical and Research Reports, May 2022, Volume 3, Issue 5 (CRR052022)
JTO Clinical and Research Reports, June 2022, Volume 3, Issue 6
JTO Clinical and Research Reports, July 2022, Volume 3, Issue 7
JTO Clinical and Research Reports, August 2022, Volume 3, Issue 8
JTO Clinical and Research Reports, September 2022, Volume 3, Issue 9
Lung Cancer Considered in French Canadian
Journal of Thoracic Oncology (JTO), January 2021, Volume 16, Issue 1
Journal of Thoracic Oncology (JTO), February 2021, Volume 16, Issue 2
Journal of Thoracic Oncology (JTO), March 2021, Volume 16, Issue 3
Journal of Thoracic Oncology (JTO), April 2021, Volume 16, Issue 4
Thoracic Oncology (JTO), May 2021, Volume 16, Issue 5
Journal of Thoracic Oncology (JTO), June 2021, Volume 16, Issue 6
Journal of Thoracic Oncology (JTO), July 2021, Volume 16, Issue 7
Journal of Thoracic Oncology (JTO), August 2021, Volume 16, Issue 8
Journal of Thoracic Oncology (JTO), September 2021, Volume 16, Issue 9
Journal of Thoracic Oncology (JTO), October 2021, Volume 16, Issue 10
Journal of Thoracic Oncology (JTO), November 2021, Volume 16, Issue 11
Journal of Thoracic Oncology (JTO), December 2021, Volume 16, Issue 12
LCC on World No Tobacco Day
JTO Clinical and Research Reports, May 2024, Volume 5, Issue 5
Journal of Thoracic Oncology (JTO), December 2020, Volume 15, Issue 12
Journal of Thoracic Oncology (JTO), November 2020, Volume 15, Issue 11
Journal of Thoracic Oncology (JTO), October 2020, Volume 15, Issue 10
An Update on Lung Cancer Screening
Journal of Thoracic Oncology (JTO), June 2024, Volume 19, Issue 6
Journal of Thoracic Oncology (JTO), September 2020, Volume 15, Issue 9
Journal of Thoracic Oncology (JTO), August 2020, Volume 15, Issue 8
The Amazing Case Race Microlearning: Case Study 5 - Refractory Gastritis and Other Immune-Related Toxicities in a Patient with a Squamous NSCLC
ASCO 2024 Highlights Part 1 - Plenary
ASCO 2024 Highlights Part 2
FDA Approval: Tarlatamab
IASLC Lung Cancer News (ILCN), June 2024
Journal of Thoracic Oncology (JTO), July 2020, Volume 15, Issue 7
Journal of Thoracic Oncology (JTO), June 2020, Volume 15, Issue 6
LCC in Italian: First Line Treatment Options for EGFR Mutant NSCLC
Journal of Thoracic Oncology (JTO), May 2020, Volume 15, Issue 5
Journal of Thoracic Oncology (JTO), April 2020, Volume 15, Issue 4
Journal of Thoracic Oncology (JTO), March 2020, Volume 15, Issue 3